Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Compass Diversified
CODI
$869M
| $227K | ﹤0.01% |
18,263
+3,354
| +22% | +$51.7K |
|
3327
National Fuel Gas
NFG
$7.84B
| $227K | ﹤0.01% |
4,445
-136,670
| -97% | -$7.49M |
|
3328
Schwab US Mid-Cap ETF
SCHM
$15B
| $227K | ﹤0.01% |
+14,229
| New | +$249K |
|
|
ALEX
3329
DELISTED
Alexander & Baldwin
ALEX
| $226K | ﹤0.01% |
12,279
-38,035
| -76% | -$766K |
|
3330
Elastic
ESTC
$8.65B
| $226K | ﹤0.01% |
+3,164
| New | +$214K |
|
|
STRS
3331
DELISTED
STRATUS PPTYS INC
STRS
| $226K | ﹤0.01% |
9,432
-14,915
| -61% | -$412K |
|
|
FARM
3332
DELISTED
Farmer Brothers
FARM
| $225K | ﹤0.01% |
+9,665
| New | +$234K |
|
3333
Syndax Pharmaceuticals
SNDX
$1.75B
| $225K | ﹤0.01% |
50,465
-557,573
| -92% | -$3.06M |
|
|
OBSV
3334
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $225K | ﹤0.01% |
17,764
-115,615
| -87% | -$1.72M |
|
3335
Cal-Maine
CALM
$3.95B
| $224K | ﹤0.01% |
5,300
-327,889
| -98% | -$15.2M |
|
|
FRAN
3336
DELISTED
Francesca's Holdings Corporation
FRAN
| $223K | ﹤0.01% |
+19,120
| New | +$557K |
|
|
CBIO
3337
Crescent Biopharma
CBIO
$630M
| $222K | ﹤0.01% |
+234
| New | +$282K |
|
3338
Nuveen Municipal Credit Income Fund
NZF
$2.4B
| $222K | ﹤0.01% |
+16,554
| New | +$224K |
|
3339
Corvus Pharmaceuticals
CRVS
$1.19B
| $221K | ﹤0.01% |
60,248
+22,878
| +61% | +$156K |
|
3340
Monarch Casino & Resort
MCRI
$2.23B
| $221K | ﹤0.01% |
+5,800
| New | +$236K |
|
3341
Commerce Bancshares
CBSH
$8.41B
| $220K | ﹤0.01% |
5,503
-54,613
| -91% | -$2.34M |
|
3342
Shore Bancshares
SHBI
$775M
| $220K | ﹤0.01% |
15,099
-20,446
| -58% | -$328K |
|
|
WDR
3343
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $220K | ﹤0.01% |
12,155
-213,007
| -95% | -$4.15M |
|
3344
Nathan's Famous
NATH
$401M
| $219K | ﹤0.01% |
3,303
| – | – |
|
|
GOLD
3345
DELISTED
Randgold Resources Ltd
GOLD
| $218K | ﹤0.01% |
2,624
-322,997
| -99% | -$26.1M |
|
3346
Telkom Indonesia
TLK
$14.8B
| $216K | ﹤0.01% |
8,257
-3,875
| -32% | -$98.5K |
|
|
BCRH
3347
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $216K | ﹤0.01% |
39,307
-44,689
| -53% | -$336K |
|
3348
Takeda Pharmaceutical
TAK
$58.2B
| $215K | ﹤0.01% |
+12,800
| New | +$216K |
|
|
GNMK
3349
DELISTED
GenMark Diagnostics, Inc
GNMK
| $214K | ﹤0.01% |
43,948
-587,496
| -93% | -$3.06M |
|
3350
Edgewell Personal Care
EPC
$1.31B
| $213K | ﹤0.01% |
5,701
-283,794
| -98% | -$12.4M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.